Stock FATE FATE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Fate Therapeutics, Inc.

Equities

FATE

US31189P1021

Market Closed - Nasdaq
Other stock markets
 21:00:00 15/05/2024 BST 		5-day change 1st Jan Change
4.24 USD +0.47% Intraday chart for Fate Therapeutics, Inc. +14.59% +13.37%
05-10 Piper Sandler Adjusts Fate Therapeutics' Price Target to $4 From $7, Keeps Neutral Rating MT
05-10 Wedbush Adjusts Fate Therapeutics' Price Target to $5 From $7, Keeps Neutral Rating MT
a5.IbDmRFlmGhJWWNXckBb7_ypzXmP00sg2eY_l4qFoFF4.dOiOASMxUVM4M4fvynOwl3w9NRmBsbtHH8yxhfkYVTZDyrcNKlR5SzALnA~d9c2b361794b6a9e425cfd65d03ca904
  1. Stock Market
  2. Equities
  3. FATE Stock
  4. Charts Fate Therapeutics, Inc.
  5. News Chart